TNKS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.551000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.539400E-01
Normal-vs-Stage2
1.526620E-01
Normal-vs-Stage3
1.862160E-02
Normal-vs-Stage4
5.062800E-01
Stage1-vs-Stage2
2.888600E-01
Stage1-vs-Stage3
5.951500E-02
Stage1-vs-Stage4
9.518800E-01
Stage2-vs-Stage3
2.014800E-01
Stage2-vs-Stage4
4.213000E-01
Stage3-vs-Stage4
4.833700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.623000E-01
Normal-vs-AfricanAmerican
5.989000E-01
Normal-vs-Asian
4.939900E-02
Caucasian-vs-AfricanAmerican
4.478000E-01
Caucasian-vs-Asian
2.390400E-01
AfricanAmerican-vs-Asian
1.154160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.118400E-01
Normal-vs-Female
1.867650E-01
Male-vs-Female
9.979000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.989800E-01
Normal-vs-Age(41-60Yrs)
4.040800E-01
Normal-vs-Age(61-80Yrs)
2.495600E-01
Normal-vs-Age(81-100Yrs)
2.087800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.201000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.304200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.054000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.822300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.098400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.999020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.553900E-02
Normal-vs-Daily Drinker
1.710470E-02
Normal-vs-Weekly Drinker
1.391190E-01
Normal-vs-Occasional Drinker
3.603800E-01
Normal-vs-Social Drinker
7.612400E-01
Non Drinker-vs-Daily Drinker
7.173200E-01
Non Drinker-vs-Weekly Drinker
5.717200E-01
Non Drinker-vs-Occasional Drinker
3.762100E-02
Non Drinker-vs-Social Drinker
3.342500E-03
Daily Drinker-vs-Weekly Drinker
4.198800E-01
Daily Drinker-vs-Occasional Drinker
2.621800E-02
Daily Drinker-vs-Social Drinker
3.045000E-03
Weekly Drinker-vs-Occasional Drinker
2.676000E-01
Weekly Drinker-vs-Social Drinker
7.036300E-02
Occasional Drinker-vs-Social Drinker
3.498800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.691380E-01
Normal-vs-Grade 2
1.355640E-02
Normal-vs-Grade 3
8.675900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.292600E-01
Grade 1-vs-Grade 3
8.438800E-01
Grade 1-vs-Grade 4
1.691380E-01
Grade 2-vs-Grade 3
5.569200E-01
Grade 2-vs-Grade 4
1.355640E-02
Grade 3-vs-Grade 4
8.675900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.412960E-01
Normal-vs-NonDiabetic
2.369200E-01
Diabetic-vs-NonDiabetic
5.402800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.377450E-01
Normal-vs-NoPancreatitis
2.378000E-01
Pancreatitis-vs-NoPancreatitis
7.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.737000E-01
Normal-vs-N1
1.314810E-01
N0-vs-N1
4.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.930190E-01
Normal-vs-TP53-NonMutant
6.685600E-01
TP53-Mutant-vs-TP53-NonMutant
1.048630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
